Riders · Board of Pharmacy · Article VIII: Regulatory
Appropriation of Official Prescription Form Fees
Rider 3 in the 2026-27 Act, page VIII-44
Through the session
- 2024-25 Act In current law rider 4
- Introduced (Senate) Amended rider 3
- Introduced (House) Amended rider 3
- Senate substitute Amended rider 3
- House substitute Unchanged rider 3
- House passed Unchanged rider 3
- Conference Unchanged rider 3
- 2026-27 Act Unchanged rider 3
Pick any two steps to compare their wording.
What changed in the text
Introduced (Senate) → Senate substitute: 202 6 became 2026; 202 7 became 2027; 202 6 became 2026; 202 6 became 2026.
Removed words are struck through; added words are underlined. Sources: Introduced (Senate) · Senate substitute.
Every version: numbers, statuses and source pages
| Version | Rider | Against the version before | Against the current budget | Source |
|---|---|---|---|---|
| 2024-25 ActGeneral Appropriations Act, 2024-25 Biennium | 4 | First version | — | Page VIII-39 |
| Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) | 3 was 4 | Amended | — | Page VIII-42 |
| Introduced (House)House Bill 1 as introduced (LBB recommended, House) | 3 was 4 | Amended | — | Page VIII-42 |
| Senate substituteCommittee Substitute for Senate Bill 1 | 3 | Amended | Updated years only | Page VIII-39 |
| House substituteHouse Committee Substitute for Senate Bill 1 | 3 | Unchanged | Updated years only | Page VIII-39 |
| House passedSenate Bill 1 as passed the second house | 3 | Unchanged | Updated years only | Page VIII-39 |
| ConferenceConference Committee Report for Senate Bill 1 | 3 | Unchanged | Updated years only | Page VIII-44 |
| 2026-27 ActGeneral Appropriations Act, 2026-27 Biennium | 3 | Unchanged | Updated years only | Page VIII-44 |
Full text of each wording
Senate substitute, House substitute, House passed, Conference, 2026-27 Act
Source, page VIII-44Appropriation of Official Prescription Form Fees. Out of the amounts appropriated above to the Board of Pharmacy from Appropriated Receipts in Strategy B.1.3, Prescription Monitoring Program, the amounts of $200,000 in fiscal year 2026 and $200,000 in fiscal year 2027 are for the production, printing, and sale of official prescription forms pursuant to Health and Safety Code, Section 481.075 from fees collected from the sale of official prescription forms. In addition to amounts appropriated above in Strategy B.1.3, Prescription Monitoring Program, any additional fees collected from the sale of official prescription forms for the production, printing, and sale of official prescription forms are appropriated for the same purpose. Any unobligated or unexpended balances of these funds remaining as of August 31, 2026, are appropriated in the fiscal year beginning September 1, 2026, for the same purpose.
Introduced (House)
Source, page VIII-42Appropriation of Official Prescription Form Fees. Out of the amounts appropriated above to the Board of Pharmacy from Appropriated Receipts in Strategy B.1.3, Prescription Monitoring Program, the amounts of $200,000 in fiscal year 2026 and $200,000 in fiscal year 202 7 are for the production, printing, and sale of official prescription forms pursuant to Health and Safety Code, Section 481.075 from fees collected from the sale of official prescription forms. In addition to amounts appropriated above in Strategy B.1.3, Prescription Monitoring Program, any additional fees collected from the sale of official prescription forms for the production, printing, and sale of official prescription forms are appropriated for the same purpose. Any unobligated or unexpended balances of these funds remaining as of August 31, 202 6, are appropriated in the fiscal year beginning September 1, 202 6, for the same purpose.
Introduced (Senate)
Source, page VIII-42Appropriation of Official Prescription Form Fees. Out of the amounts appropriated above to the Board of Pharmacy from Appropriated Receipts in Strategy B.1.3, Prescription Monitoring Program, the amounts of $200,000 in fiscal year 202 6 and $200,000 in fiscal year 202 7 are for the production, printing, and sale of official prescription forms pursuant to Health and Safety Code, Section 481.075 from fees collected from the sale of official prescription forms. In addition to amounts appropriated above in Strategy B.1.3, Prescription Monitoring Program, any additional fees collected from the sale of official prescription forms for the production, printing, and sale of official prescription forms are appropriated for the same purpose. Any unobligated or unexpended balances of these funds remaining as of August 31, 202 6, are appropriated in the fiscal year beginning September 1, 202 6, for the same purpose.
2024-25 Act
Source, page VIII-39Appropriation of Official Prescription Form Fees. Out of the amounts appropriated above to the Board of Pharmacy from Appropriated Receipts in Strategy B.1.3, Prescription Monitoring Program, the amounts of $200,000 in fiscal year 2024 and $200,000 in fiscal year 2025 are for the production, printing, and sale of official prescription forms pursuant to Health and Safety Code Section 481.075 from fees collected from the sale of official prescription forms. In addition to amounts appropriated above in Strategy B.1.3, Prescription Monitoring Program, any additional fees collected from the sale of official prescription forms for the production, printing, and sale of official prescription forms are appropriated for the same purpose. Any unobligated or unexpended balances of these funds remaining as of August 31, 2024, are appropriated in the fiscal year beginning September 1, 2024, for the same purpose.